Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The central stimulatory action of inhibitors of the dopamine uptake.

× No keyword cloud information.

12 in total

1. Glial cell-line derived neurotrophic factor (GDNF) replacement attenuates motor impairments and nigrostriatal dopamine deficits in 12-month-old mice with a partial deletion of GDNF.

Authors: Ofelia M Littrell; Ann-Charlotte Granholm; Greg A Gerhardt; Heather A Boger
Journal: Pharmacol Biochem Behav Date: 2013-01-02 Impact factor: 3.533

2. Kinetic properties of the in vivo accumulation of 3H-(-)-N-n-propylnorapomorphine in mouse brain.

Authors: S B Ross; D M Jackson
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1989-07 Impact factor: 3.000

3. "Designer" amphetamines: effects on behavior and monoamines with or without reserpine and/or alpha-methyl-para-tyrosine pretreatment.

Authors: M T Martin-Iverson; N Yamada; A W By; B A Lodge
Journal: J Psychiatry Neurosci Date: 1991-12 Impact factor: 6.186

4. Behavioural and pharmacological magnetic resonance imaging assessment of the effects of methylphenidate in a potential new rat model of attention deficit hyperactivity disorder.

Authors: Katherine N Hewitt; Yasmene B Shah; Malcolm J W Prior; Peter G Morris; Chris P Hollis; Kevin C F Fone; Charles A Marsden
Journal: Psychopharmacology (Berl) Date: 2005-04-28 Impact factor: 4.530

5. A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutramine.

Authors: D J Heal; A T Frankland; J Gosden; L J Hutchins; M R Prow; G P Luscombe; W R Buckett
Journal: Psychopharmacology (Berl) Date: 1992 Impact factor: 4.530

The central stimulatory action of inhibitors of the dopamine uptake.

1. Glial cell-line derived neurotrophic factor (GDNF) replacement attenuates motor impairments and nigrostriatal dopamine deficits in 12-month-old mice with a partial deletion of GDNF.

2. Kinetic properties of the in vivo accumulation of 3H-(-)-N-n-propylnorapomorphine in mouse brain.

3. "Designer" amphetamines: effects on behavior and monoamines with or without reserpine and/or alpha-methyl-para-tyrosine pretreatment.

4. Behavioural and pharmacological magnetic resonance imaging assessment of the effects of methylphenidate in a potential new rat model of attention deficit hyperactivity disorder.

5. A comparison of the effects of sibutramine hydrochloride, bupropion and methamphetamine on dopaminergic function: evidence that dopamine is not a pharmacological target for sibutramine.

6. PharmGKB summary: methylphenidate pathway, pharmacokinetics/pharmacodynamics.

7. (+)-AJ 76 and (+)-UH 232: central stimulants acting as preferential dopamine autoreceptor antagonists.

8. Effects of dopamine uptake inhibitors on schedule-controlled behavior in the squirrel monkey.

9. Fluoxetine at anorectic doses does not have properties of a dopamine uptake inhibitor.

10. Effects of cocaine on sodium dependent dopamine uptake in rat striatal synaptosomes.